Nautilus Biotechnology (NAUT) Change in Cash (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Change in Cash data on file, last reported at $2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 59.98% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at -$18.6 million (down 347.86% YoY), and the FY2025 full-year result was -$15.3 million, down 284.97% from the prior year.
• Change in Cash climbed to $2.2 million in Q1 2026, from -$11.5 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $23.2 million in Q4 2024 to a low of -$74.3 million in Q4 2022.
• A 5-year average of -$10.0 million and a median of -$844000.0 in 2024 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash plunged 1613.38% in 2024 and surged 244.43% in 2025, its largest moves.
• Tracing NAUT's Change in Cash over 5 years: stood at -$74.3 million in 2022, then increased by 26.37% to -$54.7 million in 2023, then soared by 142.48% to $23.2 million in 2024, then sank by 149.43% to -$11.5 million in 2025, then jumped by 119.48% to $2.2 million in 2026.
• Business Quant data shows NAUT's Change in Cash at $2.2 million in Q1 2026, -$11.5 million in Q4 2025, and -$10.6 million in Q3 2025.